Long-term exposure to polluted air can weaken the health benefits of regular exercise, according to a recent review.

President Donald Trump signed an executive order that could make it easier for scientists to study cannabis for medical use.

The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.

FDA approves Rybrevant Faspro, a subcutaneous amivantamab formulation, for all indications previously held by the intravenous formulation.

The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.

The HHS has ended several health grants to one of the nation’s largest pediatricians’ groups, a move the organization says could hurt children and families.

President Donald Trump has signed an executive order declaring the street drug fentanyl a weapon of mass destruction.

Traditional Chinese medicine (TCM) pediatric tuina may be safe and effective as supplementary therapy in children with severe pneumonia.

Early termination of the 6-minute walk test may be a practical and prognostic marker for severe adverse events in patients with COPD.

A peanut patch immunotherapy demonstrated efficacy and safety in desensitizing young children with peanut allergy in a phase 3 study.

Influenza season is getting an early start in New York City, with doctors reporting a sharp jump in cases weeks sooner than normal.

Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.